Tympa Health Technologies Ltd
UK-MF-000042174 · United Kingdom · London
Tympa Health Technologies Ltd is registered in the European database on medical devices as a manufacturer, with 12 devices declared. It is also registered as a device establishment with the U.S. FDA.
What this manufacturer declares
| Class IIa | 12 |
|---|
Among these devices, 12 are declared active.
Authorised representative in the Union: Advena Limited.
Devices declared under this manufacturer
- Charging Standard (iPhone 13)
- Tympa Assembly (iPhone 13)
- Tympa Otoscope System (Samsung A40)
- Tympa Otoscope System (iPhone 13)
- Tympa Otoscope System (iPhone XR)
Catalogue references include THA4002S, THIOSA, THPAN, THi1302, THi1302D, THi1302S.
European nomenclature codes declared: Z12149006.
United States market access
| FDA establishment register | Registered with FDA |
|---|---|
| Matched entry | TYMPA HEALTH TECHNOLOGIES LTD (GB) · FDA 3017644066 |
| Devices in EUDAMED | 12 |
| Country of registration | United Kingdom |
Device-level evidence
| Devices with a numeric GTIN | 12 |
|---|---|
| Found in the U.S. device database | 5 |
| Share | 41.7 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: United States only. Tympa Health Technologies Ltd is registered in the United States but was not found in the Canadian register.